DALLAS, Nov. 2, 2016 /PRNewswire/ -- A new hair loss prevention and reversal line launching in December 2016 is poised to disrupt the $3.5 billion hair loss market in the US where over 80 million people suffer from hair loss.
evolis® is a hair care system, that is clinically proven to reduce hair loss, increase hair density, and increase the rate of hair growth. In addition to being the first clinically validated topical hair loss product to be introduced in over 30 years, evolis® is the first product to tackle the problem at the root of its cause – by inhibiting the FGF5 protein, a crucial negative regulator of hair growth. The fgf5 gene, responsible for the production of the FGF5 protein, was discovered in 1994 by scientists at the University of California, San Francisco. They observed that in the absence of FGF5, unusually long hair was evident.
evolis® is formulated from FGF5 blocking natural plant extracts that have been screened using a number of specialized tests developed by eminent evolis® scientist, Dr. Masakuni Yamamoto. Dr. Yamamoto researched hair biology for over 20 years and is responsible for identifying the key botanical ingredients in the highly potent evolis® formulation.
Blinded, placebo controlled clinical studies using the botanical actives in evolis® have shown a significant reduction in hair loss and an increase in the number of growing hair follicles in men and women in only four months. In a 50 patient safety test, all parameters assessed over four applications reported zero side effects. To date, over 800,000 evolis® products have been sold across Japan and Australia with a strong following of loyal customers and zero complaints.
"evolis® changed my life, and I'm so thrilled to be able to share this product with the millions of Americans who suffer physically and emotionally from hair loss" says Maria Halasz, CEO, evolis®. "As someone who began losing her hair at age 40, I deeply relate with women who suffer from a lack of confidence and loss of hope because of thinning hair."
The evolis® hair care system easily fits into anyone's standard routine - a shampoo, a conditioner, an activator (the hero product), and a treatment mask. evolis® is approved for all types of hair, is color-safe, and is sulfate, paraben, silicone and cruelty-free. The first line from evolis® is REVERSE, for those already experiencing hair loss and thinning, is available for pre-order on www.evolisprofessional.com, while PREVENT for younger men and PROMOTE, for younger women wishing to grow their hair faster, will be available in March 2017.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/evolis-introduces-science-backed-fgf5-inhibiting-hair-care-line-for-hair-loss-reversal-and-prevention-300355875.html